Research fellow dal 1 marzo 2024 per un progetto presso il Dipartimento di Medicina Sperimentale (DIMES), Università degli Studi di Genova. Impiego di EVs da cellule progenitrici umane in un modello preclinico di fibrosi cardiaca umana su microchip [...]
POSTDOCTORAL POSITION in Computational Oncology University of Torino, ITALY TARGET: Targeting DNA repair pathways, sparking anti-cancer immunity An ERC-funded postdoctoral position is available in the Laboratory of Prof. Bardelli at the Dep. of Oncology, University [...]
POSTDOCTORAL POSITION in Molecular Oncology University of Torino, ITALY TARGET: Targeting DNA repair pathways, sparking anti-cancer immunity An ERC-funded postdoctoral position is available in the Laboratory of Prof. Bardelli at the Dep. of Oncology, University [...]
Postdoctoral position available at the Department of Molecular Medicine and Medical Biotechnologies University of Naples “Federico II” “Role of (macro)autophagy in the regulation of turn-over, unconventional secretion and inter-neuronal spreading of neurodegenerative diseasesassociated aggregation-prone proteins.” We are [...]
Università degli Studi di Trieste Department of Life Sciences A short term post-doctoral position is immediately available in the laboratory of prof. Licio Collavin at the University of Trieste (http://tinyurl.com/collavinlab) The lab is focused on the molecular [...]
A new position available at University of Genoa Department of Experimental Medicine, section of Cellular Biology Research position will be available in March 2023 at University of Genoa - Department of Experimental Medicine, section of Cellular [...]
Postdoctoral Position (3 Years) on human iPSCs in neurodevelopmental disorders The project will deal with the Analysis of Neuronal Populations Derived from Human iPS cells (hiPSCs) with deletions/duplications at the 16p11.2 chromosomal region. Carriers at 16p11.2 [...]
POST-DOC FELLOWSHIP The role of MEF2A-HDAC5 axis in leiomyosarcoma aggressiveness - University of Udine First year project – Leiomyosarcoma (LMS) ia an aggressive cancer, local recurrence and metastasis develop in approximately 40% of cases. The class [...]
